← FDA Drug Approvals (Drugs@FDA)

BUPIVACAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2023-06-23

Drug application

FDA Application #

ANDA216039

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUPIVACAINE HYDROCHLORIDE

Generic name

BUPIVACAINE HYDROCHLORIDE

Active ingredients

BUPIVACAINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

MEITHEAL

Manufacturer

Northstar Rx LLC

First approval

2023-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown